Most Cases of Cryptogenic Cirrhosis May Be Nonobese Nonalcoholic Steatohepatitis- Risk Factors of Liver Steatosis After Liver Transplantation for Cryptogenic Cirrhosis: A Retrospective Study

Objective The course of cryptogenic cirrhosis (CC) after liver transplantation (LT) is unknown. We there-fore clarified the natural course post-LT for CC and investigated the etiology of CC.Methods Eighteen patients who underwent LT for CC were included. To rule out the possibility of nonal-coholic steatohepatitis (NASH) in patients with CC, those with a history of obesity or liver steatosis found pretransplantation were excluded. A liver biopsy was performed one year after LT and annually thereafter.Results Liver steatosis and steatohepatitis were identified in 61% and 39% of patients after LT, respectively, with a median time to the onset of 12 and 27 months, respectively. There were no other pathological findings such as liver allograft rejection, autoimmune hepatitis, or primary biliary cholangitis. The body mass index after LT (28.5 vs. 22.4 kg/m2; p=0.002) and mean muscle attenuation at the time of LT were significantly higher (33.3 vs. 25.8 Hounsfield units, p=0.03) and the postoperative hospitalization period shorter (50 vs. 102 days; p=0.02) in the steatosis group than in the non-steatosis group. Recipients were significantly younger in the steatohepatitis subgroup than in the simple steatosis subgroup (55.0 vs. 63.5 years old; p= 0.04).Conclusion Despite excluding CC patients with a history of obesity, we observed that patients with CC had a high prevalence of steatosis after LT than those without CC. Young patients with a favorable postoperative course were noted to have a high risk of NASH after LT for CC. Patients with CC may represent cases of non-obese NASH.

Automated summary

This study investigated the natural course of cryptogenic cirrhosis after liver transplantation and the etiology of cryptogenic cirrhosis. It was found that patients with cryptogenic cirrhosis had a high prevalence of liver steatosis and steatohepatitis, with younger patients having a higher risk of non-alcoholic steatohepatitis.